Cumberland Pharmaceuticals Beheer
Beheer criteriumcontroles 3/4
Cumberland Pharmaceuticals' CEO is A. Kazimi, appointed in Jan 1999, has a tenure of 25.83 years. total yearly compensation is $1.17M, comprised of 57.7% salary and 42.3% bonuses, including company stock and options. directly owns 40.43% of the company’s shares, worth $6.38M. The average tenure of the management team and the board of directors is 6.9 years and 11.5 years respectively.
Belangrijke informatie
A. Kazimi
Algemeen directeur
US$1.2m
Totale compensatie
| Percentage CEO-salaris | 57.7% |
| Dienstverband CEO | 25.8yrs |
| Eigendom CEO | 40.4% |
| Management gemiddelde ambtstermijn | 6.9yrs |
| Gemiddelde ambtstermijn bestuur | 11.5yrs |
Recente managementupdates
Recent updates
Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Nov 04
Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Mar 07Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Prospects Need A Boost To Lift Shares
Jan 09Why Investors Shouldn't Be Surprised By Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Low P/S
Oct 02Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Aug 10Does Cumberland Pharmaceuticals (NASDAQ:CPIX) Have A Healthy Balance Sheet?
Mar 18Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Nov 02Calculating The Fair Value Of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)
Jul 20Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?
Apr 15Checking In On Cumberland Pharmaceuticals
Jan 04Health Check: How Prudently Does Cumberland Pharmaceuticals (NASDAQ:CPIX) Use Debt?
Nov 09We Think Some Shareholders May Hesitate To Increase Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) CEO Compensation
Apr 21Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Debt In A Risky Way?
Feb 13One Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Analyst Just Cut Their EPS Forecasts
Nov 19
Cumberland Pharmaceuticals Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 11Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$10m |
| Mar 31 2024 | n/a | n/a | -US$8m |
| Dec 31 2023 | US$1m | US$675k | -US$6m |
| Sep 30 2023 | n/a | n/a | -US$2m |
| Jun 30 2023 | n/a | n/a | -US$2m |
| Mar 31 2023 | n/a | n/a | -US$4m |
| Dec 31 2022 | US$1m | US$635k | -US$6m |
| Sep 30 2022 | n/a | n/a | -US$7m |
| Jun 30 2022 | n/a | n/a | -US$9m |
| Mar 31 2022 | n/a | n/a | -US$7m |
| Dec 31 2021 | US$1m | US$610k | -US$6m |
| Sep 30 2021 | n/a | n/a | -US$3m |
| Jun 30 2021 | n/a | n/a | -US$3m |
| Mar 31 2021 | n/a | n/a | -US$5m |
| Dec 31 2020 | US$1m | US$590k | -US$7m |
| Sep 30 2020 | n/a | n/a | -US$8m |
| Jun 30 2020 | n/a | n/a | -US$10m |
| Mar 31 2020 | n/a | n/a | -US$10m |
| Dec 31 2019 | US$1m | US$567k | -US$9m |
| Sep 30 2019 | n/a | n/a | -US$8m |
| Jun 30 2019 | n/a | n/a | -US$6m |
| Mar 31 2019 | n/a | n/a | -US$6m |
| Dec 31 2018 | US$1m | US$545k | -US$11m |
| Sep 30 2018 | n/a | n/a | -US$6m |
| Jun 30 2018 | n/a | n/a | -US$5m |
| Mar 31 2018 | n/a | n/a | -US$9m |
| Dec 31 2017 | US$1m | US$523k | -US$8m |
Compensatie versus markt: A.'s total compensation ($USD1.17M) is above average for companies of similar size in the US market ($USD655.65K).
Compensatie versus inkomsten: A.'s compensation has been consistent with company performance over the past year.
CEO
A. Kazimi (66 yo)
25.8yrs
Tenure
US$1,169,530
Compensatie
Mr. A. J. Kazimi, MBA, founded Cumberland Pharmaceuticals Inc. in 1999 and has been its Chairman and Chief Executive Officer since 1999. Mr. Kazimi serves as the President of Cumberland Pharmaceuticals Inc...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | 25.8yrs | US$1.17m | 40.43% $ 6.4m | |
| VP & CFO | 3.5yrs | US$282.32k | 0.18% $ 29.1k | |
| Executive VP of National Accounts & Chief Compliance Officer | 8.1yrs | US$400.15k | 0.27% $ 42.8k | |
| Vice President of Sales & Marketing | no data | US$316.29k | 0.033% $ 5.2k | |
| Vice President of Organizational Development | no data | US$330.85k | 0.12% $ 18.3k | |
| Senior VP of Administrative Services & Corporate Secretary | no data | US$298.01k | geen gegevens | |
| Managing Director | 5.8yrs | geen gegevens | geen gegevens | |
| Senior Corporate Relations Associate | no data | geen gegevens | geen gegevens |
6.9yrs
Gemiddelde duur
66yo
Gemiddelde leeftijd
Ervaren management: CPIX's management team is seasoned and experienced (6.9 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | 25.8yrs | US$1.17m | 40.43% $ 6.4m | |
| Member of Pharmaceutical Advisory Board | no data | geen gegevens | geen gegevens | |
| Independent Director | 6.2yrs | US$61.20k | 0.42% $ 66.5k | |
| Member of Medical Advisory Board | no data | geen gegevens | geen gegevens | |
| Chairman of Medical Advisory Board & Independent Director | 14.8yrs | US$98.00k | geen gegevens | |
| Member of Pharmaceutical Advisory Board | no data | US$233.65k | geen gegevens | |
| Director | 2.3yrs | US$50.00k | 0.043% $ 6.7k | |
| Member of Medical Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Pharmaceutical Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Medical Advisory Board | no data | geen gegevens | geen gegevens | |
| Independent Director | 8.2yrs | US$61.20k | 0.20% $ 31.7k | |
| Independent Director | 14.8yrs | US$60.20k | geen gegevens |
11.5yrs
Gemiddelde duur
72yo
Gemiddelde leeftijd
Ervaren bestuur: CPIX's board of directors are seasoned and experienced ( 11.5 years average tenure).